Table 1.
Baseline characteristics
| Age (years) | 55 (8; 137) |
| Race – n (%) | |
| Black | 61 (44) |
| White | 68 (49) |
| Other | 9 (7) |
| BMI (kg/m2) | 32 (6; 117) |
| Diabetes mellitus – n (%) | 27 (21) |
| Hypertension – n (%) | 56 (42) |
| Total testosterone (ng/dL) | 251 (65; 140) |
| Free testosterone (pg/mL) | 46 (15; 138) |
| Dihydrotestosterone (ng/dL) | 24 (11; 132) |
| Oestradiol (pg/mL) | 28 (10; 132) |
| Androstenedione (ng/dL) | 247 (102; 133) |
| Oestrone (pg/mL) | 41 (16; 132) |
| Luteinizing hormone (U/L) | 5.6 (3.7; 133) |
| Follicle-stimulating hormone (U/L) | 6.4 (5.2; 133) |
| DHEAS (lg/dL) | 115 (70; 133) |
| SHBG (nmol/L) | 31 (16; 119) |
| Inhibin B (pg/mL) | 141 (51; 133) |
BMI, body mass index; DHEAS, dehydroepiandrosterone sulphate; SHBG, sex hormone binding globulin. Continuous variables are described as mean (SD; n). Numbers of participants are less than 140 ascribable to missing data.